Rhythm Pharmaceuticals (RYTM) Capital Expenditures Growth (3y) (2020 - 2026)
Rhythm Pharmaceuticals (RYTM) Capital Expenditures Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,011.97 Bn | 67,011.68 Bn | - | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.88 Bn | 467.08 Bn | 1.35 Bn | -12.25% |
| 5 | Vertex Pharmaceuticals | 122.20 Bn | 114.96 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.17 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.85 Bn | 50.67 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | 16.27% |
| 10 | Rhythm Pharmaceuticals | 7.29 Bn | 6.95 Bn | 52.96 Mn | -85.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -85.60% |
| Dec 31, 2025 | 29.05% |
| Sep 30, 2025 | 4.05% |
| Jun 30, 2025 | -352.09% |
| Mar 31, 2025 | -41.00% |
| Dec 31, 2024 | 35.04% |
| Sep 30, 2024 | -27.82% |
| Jun 30, 2024 | -84.20% |
| Mar 31, 2024 | -366.60% |
| Dec 31, 2023 | -63.75% |
| Sep 30, 2022 | 161.92% |
| Jun 30, 2022 | -70.41% |
| Mar 31, 2022 | -46.10% |
| Dec 31, 2021 | 48.06% |
| Sep 30, 2021 | 218.82% |
| Dec 31, 2020 | 15.16% |